#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Henoch-Schonlein purpura nephritis Aicardi-Goutieres syndrome Exudative retinopathy Bronchopulmonary dysplasia Autoimmune myositis Subarachnoid haemorrhage Thrombotic microangiopathy IPEX syndrome Microscopic polyangiitis Chemical burn Blastic plasmacytoid dendritic cell neoplasia Haemophilia B with anti factor IX Adrenogenital syndrome Infantile apnoea Erythema multiforme More trials…

    Learn about Rare Diseases

    Synovial sarcoma – Trials in Disease Mantle cell lymphoma stage IV – Diagnostics Rhabdomyosarcoma recurrent – Basic Information Combined immunodeficiency – Basic Information Alexander disease – Treatment Wiskott-Aldrich syndrome – Life with Disease Myxofibrosarcoma – Diagnostics Haemolytic uraemic syndrome Ewing’s sarcoma – Treatment Adrenocortical carcinoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Lactate Gluconate Canis Familiaris (553) Selgantolimod Sonelokimab Atidarsagene Autotemcel Azithromycin Dihydrate Meropenem Pyrimethamine Goserelin Argipressin Tenofovir Disoproxil Fumarate S230815-2 Gliquidone BI-1607 H2-Receptor Antagonists Aup1602-C Volixibat INSULIN DEGLUDEC Camphor Cusatuzumab More therapies…

    Learn about Your Condition

    Scoliosis Neurodermatitis Anogenital dysplasia Pancreatic carcinoma recurrent Peyronie's disease Breast cancer stage III Advanced systemic mastocytosis Diminished ovarian reserve Cerebrovascular accident Adenomyosis Henoch-Schonlein purpura Respiratory failure Infectious pleural effusion Inclusion body myositis Dermatitis atopic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of TOL2 safety and immune response in patients with generalized myasthenia gravis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Human Albumin Solution
    • Glucose
    • Human Normal Immunoglobulin (Iv)
    Denmark Germany Sweden

  • Study of B Cell Response to Tetanus Toxoid Vaccination in Patients with Systemic Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Systemic lupus erythematosus
    • Systemic scleroderma
    Investigated Drugs:
    • TETANUS TOXOID
    The Netherlands

  • Safety and imaging quality study of perflutren contrast agent (HarMono-T) during kidney ultrasound in healthy volunteers

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Perflutren
    Germany

  • Safety and efficacy study of nadofaragene firadenovec administered to the renal pelvis in adults with low-grade upper tract urothelial carcinoma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • NADOFARAGENE FIRADENOVEC
    France The Netherlands Spain

  • Study comparing CHF 5993 (beclometasone/formoterol/glycopyrronium) to fluticasone/salmeterol inhalation in adolescents with uncontrolled asthma on medium-dose inhaled therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Salmeterol
    • Fluticasone Propionate
    Germany Italy Spain

  • Comparison of compression therapy alone versus compression therapy with phenoxymethylpenicillin for preventing recurrent erysipelas in lower limbs

    Not yet recruiting

    3 1 1 1
    France
Previous Page
1 … 768 769 770 771 772 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!